Open

Bladder Cancer Treatment Study

This study will test a faster radiation treatment for bladder cancer. We want to see if this shorter method can keep the bladder healthy and cancer-free for three years, just like the usual treatment does.

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

North Carolina (Statewide)

What will be asked of you

As a participant, you will meet with a team member and complete questionnaires. You will also have blood tests and receive radiation and chemotherapy treatments.

In-person visits:
4-25

Phone or online visits:
4-25

Total length of participation:
60 months

Looking for Specific Volunteers

Able to participate:

The cancer has grown into the muscle layer of the bladder (T2) or into the fat surrounding the bladder (T3), but not beyond.
Must undergone removal of bladder tumor(s) and staging prior to randomization
No bladder cancer outside the bladder in the past 2 years, unless fully removed from the kidney or ureter and was early-stage (Ta/T1/CIS)

Not eligible if:

Under 18 years of age
Pregnant and/or Nursing a child
Must not have evidence of T4 or node positive disease.

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Michael Repka
Lineberger Comprehensive Cancer Center

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Bladder)
Urinary and Bladder

IRB Number

25-2430

ClinicalTrials.gov

NCT07097142

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.